Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation NY Valves 2025

The Effect of Transcatheter Aortic Valve Replacement With JenaValve Trilogy on 1-Year Reverse Remodeling in Patients With Pure Aortic Regurgitation Stratified by Baseline LV Function

Presenter: Lauren Sharan Ranard

June 27, 2025

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

Presentation NY Valves 2024

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Presenter: Sahar Samimi

June 07, 2024

Presentation NY Valves 2024

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

Presenter: Matti Adam

June 07, 2024

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Presentation NY Valves 2024

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Presenter: Raj Makkar

June 07, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Implantation for Pure Aortic Valve Regurgitation? Insights From the France-TAVI Nationwide French Registry: The PAVR Study

Presenter: Robin Le Ruz

June 07, 2024

Presentation NY Valves 2024

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Presenter: Jonathan Curio

June 06, 2024

Presentation NY Valves 2024

Transcatheter Heart Valve for Treatment of Pure Native AR With Minimal AV Calcium, Large Annulus and Large Aorta

Presenter: Hasan Jilaihawi

June 06, 2024

Presentation NY Valves 2024

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

Presenter: Arianna Favela

June 06, 2024

Presentation NY Valves 2024

Current Status of Dedicated Valve Platforms for Pure Aortic Regurgitation and Update on Trial Data

Presenter: Torsten P. Vahl

June 05, 2024

Presentation NY Valves 2024

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

Presenter: Raj Makkar

June 05, 2024

Presentation NY Valves 2024

Why is TAVR Needed for Chronic Severe AR: Contemporary Insights

Presenter: Vinod H. Thourani

June 05, 2024

Presentation NY Valves 2024

What's Needed to "Modernize" the Guidelines for Chronic Severe Aortic Regurgitation?

Presenter: Santiago Garcia

June 05, 2024

Presentation NY Valves 2024

Innovation in TAVR for Pure AR (J Valve)

Presenter: Tsuyoshi Kaneko

June 05, 2024

Advertisement

The Effect of Transcatheter Aortic Valve Replacement With JenaValve Trilogy on 1-Year Reverse Remodeling in Patients With Pure Aortic Regurgitation Stratified by Baseline LV Function

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Transcatheter Aortic Valve Implantation for Pure Aortic Valve Regurgitation? Insights From the France-TAVI Nationwide French Registry: The PAVR Study

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Transcatheter Heart Valve for Treatment of Pure Native AR With Minimal AV Calcium, Large Annulus and Large Aorta

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

Current Status of Dedicated Valve Platforms for Pure Aortic Regurgitation and Update on Trial Data

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

Why is TAVR Needed for Chronic Severe AR: Contemporary Insights

What's Needed to "Modernize" the Guidelines for Chronic Severe Aortic Regurgitation?

Innovation in TAVR for Pure AR (J Valve)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content